These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

199 related items for PubMed ID: 21343576

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Doxorubicin plus sorafenib vs doxorubicin alone in patients with advanced hepatocellular carcinoma: a randomized trial.
    Abou-Alfa GK, Johnson P, Knox JJ, Capanu M, Davidenko I, Lacava J, Leung T, Gansukh B, Saltz LB.
    JAMA; 2010 Nov 17; 304(19):2154-60. PubMed ID: 21081728
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Sorafenib therapy in patients with hepatocellular carcinoma before liver transplantation.
    Rowe IA.
    Hepatology; 2010 Sep 17; 52(3):1171-2. PubMed ID: 20812364
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Hepatocellular carcinoma: sorafenib before liver transplantation?
    Braillon A.
    Hepatology; 2010 Jun 17; 51(6):2232-3. PubMed ID: 20041410
    [No Abstract] [Full Text] [Related]

  • 7. Candidacy for sorafenib in HCC patients: is there a slippery slope beyond a SHARP edge?
    Burak KW.
    Oncology (Williston Park); 2011 Mar 17; 25(3):296, 298, 300. PubMed ID: 21548474
    [No Abstract] [Full Text] [Related]

  • 8. Sorafenib: in hepatocellular carcinoma.
    Simpson D, Keating GM.
    Drugs; 2008 Mar 17; 68(2):251-8. PubMed ID: 18197728
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Commentary: Sorafenib -- the end of a long journey in search of systemic therapy for hepatocellular carcinoma, or the beginning?
    Abou-Alfa GK.
    Oncologist; 2009 Jan 17; 14(1):92-4. PubMed ID: 19144679
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Sorafenib for liver cancer: the horizon broadens.
    Johnson P, Billingham L.
    Lancet Oncol; 2009 Jan 17; 10(1):4-5. PubMed ID: 19111238
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Sorafenib in advanced hepatocellular carcinoma.
    Copur MS.
    N Engl J Med; 2008 Dec 04; 359(23):2498; author reply 2498-9. PubMed ID: 19065701
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.